STOCK TITAN

Zhongchao Inc. (ZCMD) Financials

ZCMD
FY2025 annual
Revenue $11.4M -28.3% YoY
Net Income -$6.3M -881.0% YoY
EPS (Diluted) -$1.85 YoY not available
Operating Cash Flow $845K +157.4% YoY
Market Cap $6.2M as of Oct 15, 2026
Price / Sales 0.5x on $11.4M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.3x on $18.6M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the F-1/A for FY2025, filed May 22, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ZCMD SEC filings page.

Zhongchao Inc. (ZCMD) reported $11.4M in revenue for fiscal year 2025, down 28.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ZCMD FY2025

Zhongchao's low-debt business saw earnings weaken sharply while cash flow stayed positive through working-capital movement.

Debt-to-equity was just 0.1x and the current ratio was 11.1x in FY2025, indicating that earnings deterioration was not accompanied by heavy balance-sheet leverage or near-term liquidity strain. Equity fell from $20.8M to $18.6M, leaving a smaller cushion even without debt escalation.

SG&A nearly doubled from $5.0M to $9.8M, so overhead expanded while the business became smaller. Revenue fell 28.3%, reducing the gross-profit pool available to carry that cost base.

Operating cash flow was positive at $845K even as net loss reached $6.3M, so the cash result was better than the accounting result without reflecting improved profitability. Receivables fell from $4.7M to $2.8M, pointing to working-capital release as a likely contributor to that divergence.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 33 / 100
Financial Health Score 33/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Zhongchao Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
86

Zhongchao Inc. held $15.2M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $845K of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Zhongchao Inc. scores 86/100 among other emerging companies.

Dilution
0

Not available for Zhongchao Inc., and counted as zero in the overall score.

R&D Intensity
2

Zhongchao Inc. spent $8K on research and development in fiscal year 2025, which was 0.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Zhongchao Inc. scores 2/100 among other emerging companies.

Revenue Progress
16

Zhongchao Inc. reported revenue of $11.4M in fiscal year 2025, against $15.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Zhongchao Inc. scores 16/100 among other emerging companies.

Burn Trend
0

Not available for Zhongchao Inc., and counted as zero in the overall score.

Balance Sheet
96

Zhongchao Inc.'s cash, cash equivalents and investments came to $15.2M at the end of fiscal year 2025, against $1.5M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Zhongchao Inc. scores 96/100 among other emerging companies.

Altman Z-Score Grey Zone
1.96

Zhongchao Inc. scores 1.96, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($6.2M) relative to total liabilities ($1.5M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/7

Zhongchao Inc. passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed
N/A

Zhongchao Inc. reported a net loss of $6.3M while generating $845K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Zhongchao Inc. reported an operating loss of $6.2M against $343K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$8.1M
YoY+3.3%
QoQ-9.1%

Zhongchao Inc. held $8.1M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

ZCMD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZCMD quarterly income statement
MetricQ4'25F-1/AQ2'256-KQ4'24F-1/AQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-Q

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

ZCMD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZCMD quarterly balance sheet
MetricQ4'25F-1/AQ2'256-KQ4'24F-1/AQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-Q
Total Assets$24.1M-6.7%$26.3M+9.5%$25.9M+6.0%$24.0M-21.3%$24.4M-36.8%$30.5M-21.0%$38.6M+6.5%$38.7M+5.2%
Current Assets$17.0M-9.3%$19.1M+14.4%$18.7M0.0%$16.7M-10.0%$18.7M-17.6%$18.6M-34.0%$22.7M-16.7%$28.1M-3.6%
Cash & Equivalents$8.1M+3.3%$8.9M+41.9%$7.8M+3.9%$6.3M-44.4%$7.5M-34.5%$11.3M-1.7%$11.5M-17.2%$11.5M-9.3%
Short-Term Investments$5.8M+11.1%$6.1M+3.0%$5.2M-11.1%$5.9M+534.7%$5.9M+1037.7%$936K+78.5%$518K+75.0%$524K-82.1%
InventoryN/AN/A$586K-1.0%$301K-41.4%$592K+213.3%$513K$189KN/A
Accounts Receivable$2.8M-40.6%$3.5M+25.7%$4.7M+83.4%$2.8M-17.9%$2.6M-62.3%$3.4M-65.2%$6.8M-26.5%$9.7M-7.1%
Long-Term Investments$1.2M+12.9%$1.2M$1.1M$0$0-100.0%$0$1.2M-40.8%$0
GoodwillN/AN/AN/AN/AN/A$5.5M$5.8MN/A
Total Liabilities$1.5M-10.7%$2.6M-22.8%$1.7M-48.7%$3.3M-1.2%$3.4M-39.6%$3.4M-37.7%$5.6M+51.2%$5.4M+48.1%
Current Liabilities$1.5M-0.2%$2.3M-15.2%$1.5M-42.9%$2.8M+58.7%$2.7M-35.7%$1.7M-55.8%$4.2M+16.1%$3.9M+8.7%
Non-Current Liabilities$22K-89.1%$214K-61.1%$203K-70.9%$550K-65.9%$700K-51.0%$1.6M+11.6%$1.4M+1170.1%$1.4M+11224.6%
Long-Term DebtN/AN/AN/AN/AN/AN/A$1.8M-30.8%N/A
Total Equity$18.6M-10.6%$20.3M+14.7%$20.8M+15.7%$17.7M-27.3%$18.0M-39.8%$24.3M-27.0%$29.9M-8.1%$33.3M+0.4%
Retained Earnings-$14.2M-78.3%-$8.9M-25.0%-$8.0M-9.5%-$7.1M-1090.7%-$7.3M-276.2%-$598K-108.2%$4.1M-42.6%$7.3M-12.8%

ZCMD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZCMD quarterly cash flow statement
MetricQ4'25F-1/AQ2'256-KQ4'24F-1/AQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-Q

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

ZCMD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZCMD quarterly financial ratios
MetricQ4'25F-1/AQ2'256-KQ4'24F-1/AQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-Q
Current Ratio11.11-1.1x8.15+2.1x12.22+5.2x6.05-4.6x6.99+1.5x10.66+3.5x5.45-2.1x7.14-0.9x
Debt-to-Equity0.080.0x0.13-0.1x0.08-0.1x0.190.0x0.19+0.1x0.140.0x0.060.0x0.16+0.1x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Zhongchao Inc. ZCMD FY2025 $11.4M -$6.3M -55.5% $6.2M 33/100
OneMedNet Corp ONMD FY2025 $1.4M -$2.8M N/A $27.4M 17/100
Mangoceuticals, Inc. MGRX FY2025 $456K -$20.6M N/A $7.3M —
Healthcare Triangle, Inc. HCTI FY2025 $13.9M -$9.5M -68.2% $5.6M 30/100
Heartbeam, Inc. BEAT FY2025 N/A -$21.0M N/A $22.1M —

Frequently Asked Questions

What is Zhongchao Inc.'s annual revenue?

Zhongchao Inc. (ZCMD) reported $11.4M in total revenue for fiscal year 2025. This represents a -28.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Zhongchao Inc.'s revenue growing?

Zhongchao Inc. (ZCMD) revenue declined by 28.3% year-over-year, from $15.9M to $11.4M in fiscal year 2025.

Is Zhongchao Inc. profitable?

No, Zhongchao Inc. (ZCMD) reported a net income of -$6.3M in fiscal year 2025, with a net profit margin of -55.5%.

Zhongchao Inc. (ZCMD) reported diluted earnings per share of -$1.85 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Zhongchao Inc. (ZCMD) had EBITDA of -$5.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Zhongchao Inc. (ZCMD) had a gross margin of 45.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Zhongchao Inc. (ZCMD) had an operating margin of -54.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Zhongchao Inc. (ZCMD) had a net profit margin of -55.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Zhongchao Inc. (ZCMD) has a return on equity of -33.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Zhongchao Inc. (ZCMD) generated $845K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Zhongchao Inc. (ZCMD) had $24.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Zhongchao Inc. (ZCMD) invested $8K in research and development during fiscal year 2025.

Zhongchao Inc. (ZCMD) had a current ratio of 11.11 as of fiscal year 2025, which is generally considered healthy.

Zhongchao Inc. (ZCMD) had a debt-to-equity ratio of 0.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Zhongchao Inc. (ZCMD) had a return on assets of -26.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Zhongchao Inc. (ZCMD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $6.2M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Zhongchao Inc. (ZCMD) trades at 0.5x sales, its market capitalization divided by revenue of $11.4M revenue, FY2025. The market capitalization is $6.2M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Zhongchao Inc. (ZCMD) has an Altman Z-Score of 1.96, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Zhongchao Inc. (ZCMD) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Zhongchao Inc. (ZCMD) reported a net loss of $6.3M while generating $845K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Zhongchao Inc. (ZCMD) reported an operating loss of $6.2M against $343K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Zhongchao Inc. (ZCMD) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top